INDT

234.6

+1.3%↑

SAGAD

34.15

+0.59%↑

CAST

113

+0.09%↑

PNDX.B

174

+0.69%↑

WIHL

97.2

+0.36%↑

INDT

234.6

+1.3%↑

SAGAD

34.15

+0.59%↑

CAST

113

+0.09%↑

PNDX.B

174

+0.69%↑

WIHL

97.2

+0.36%↑

INDT

234.6

+1.3%↑

SAGAD

34.15

+0.59%↑

CAST

113

+0.09%↑

PNDX.B

174

+0.69%↑

WIHL

97.2

+0.36%↑

INDT

234.6

+1.3%↑

SAGAD

34.15

+0.59%↑

CAST

113

+0.09%↑

PNDX.B

174

+0.69%↑

WIHL

97.2

+0.36%↑

INDT

234.6

+1.3%↑

SAGAD

34.15

+0.59%↑

CAST

113

+0.09%↑

PNDX.B

174

+0.69%↑

WIHL

97.2

+0.36%↑

Search

Hufvudstaden AB (Class A)

Geschlossen

119.3 -0.25

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

118.4

Max

119.6

Schlüsselkennzahlen

By Trading Economics

Einkommen

-724M

103M

Verkäufe

-34M

810M

KGV

Branchendurchschnitt

28.966

43.654

EPS

1.18

Dividendenrendite

2.32

Gewinnspanne

12.752

Angestellte

248

EBITDA

-224M

187M

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

2.32%

6.00%

Nächstes Ergebnis

21. Aug. 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

607M

24B

Vorheriger Eröffnungskurs

119.55

Vorheriger Schlusskurs

119.3

Hufvudstaden AB (Class A) Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

4. Aug. 2025, 21:42 UTC

Ergebnisse
Akquisitionen, Fusionen, Übernahmen

Cabot to Acquire Mexico Carbon Manufacturing From Bridgestone

4. Aug. 2025, 21:21 UTC

Ergebnisse
Wichtige Markttreiber

Vertex Stock Falls After Pain-Drug Setback, Despite Stronger 2Q Earnings -- Update

4. Aug. 2025, 20:45 UTC

Ergebnisse

Vertex Pharmaceuticals Swings to 2Q Profit as Sales Climb

4. Aug. 2025, 19:15 UTC

Wichtige Markttreiber

TransMedics Group Shares Rise on FDA Approval for Clinical Trial

4. Aug. 2025, 23:41 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

4. Aug. 2025, 23:41 UTC

Market Talk

Nikkei May Rise on Fed Stimulus Hopes

4. Aug. 2025, 23:28 UTC

Market Talk

Global Equities Roundup: Market Talk

4. Aug. 2025, 23:28 UTC

Market Talk

Gold Seen Stuck in Range as Investors Await Fed's Next Move -- Market Talk

4. Aug. 2025, 21:30 UTC

Ergebnisse

Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com

4. Aug. 2025, 21:21 UTC

Ergebnisse
Akquisitionen, Fusionen, Übernahmen

Berkshire Stock Was Hammered Monday. It's Like 1999 Again. -- Barrons.com

4. Aug. 2025, 21:18 UTC

Ergebnisse

Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com

4. Aug. 2025, 20:25 UTC

Market Talk

India Hits Back Over Russian Oil Purchases -- Market Talk

4. Aug. 2025, 20:25 UTC

Ergebnisse

Transocean 2Q Loss $938M >RIG

4. Aug. 2025, 20:25 UTC

Ergebnisse

Transocean 2Q Loss/Shr $1.06 >RIG

4. Aug. 2025, 20:18 UTC

Ergebnisse

Palantir Stock Jumps. Earnings Blew Past Wall Street's Stratospheric Expectations. -- Barrons.com

4. Aug. 2025, 20:15 UTC

Ergebnisse

Vertex Pharma: Guidance Includes Immaterial Cost Impact From Tariffs in 2025 Based on Currently Known Tariff Rates and Regulations >VRTX

4. Aug. 2025, 20:14 UTC

Ergebnisse

Vertex Pharmaceuticals Reiterated FY25 Fincl Guidance >VRTX

4. Aug. 2025, 20:14 UTC

Ergebnisse

Vertex Pharma: Mark Bunnage, D.Phil., SVP of Global Research, to Assume Role of CSO Effective Feb 1, 2026 >VRTX

4. Aug. 2025, 20:14 UTC

Ergebnisse

Vertex Pharma: David Altshuler, Chief Scientific Officer, Intends to Retire Aug 1, 2026 >VRTX

4. Aug. 2025, 20:13 UTC

Ergebnisse

Vertex Pharmaceuticals Backs FY25 Rev $11.85B-$12B >VRTX

4. Aug. 2025, 20:09 UTC

Ergebnisse

Viper Energy: Initiating Avg Daily Production Guidance for 3Q of 46,000 to 49,000 Bo/d (86,000 to 92,000 Boe/d) >VNOM

4. Aug. 2025, 20:06 UTC

Ergebnisse

Palantir Earnings Blow Past Wall Street's Stratospheric Expectations -- Barrons.com

4. Aug. 2025, 20:01 UTC

Ergebnisse

Vertex Pharmaceuticals 2Q Net $1.03B >VRTX

4. Aug. 2025, 20:01 UTC

Ergebnisse

Vertex Pharmaceuticals 2Q Adj EPS $4.52 >VRTX

4. Aug. 2025, 20:01 UTC

Ergebnisse

Vertex Pharmaceuticals 2Q Rev $2.96B >VRTX

4. Aug. 2025, 20:01 UTC

Ergebnisse

Vertex Pharmaceuticals 2Q EPS $3.99 >VRTX

4. Aug. 2025, 19:41 UTC

Market Talk

U.S. Natural Gas Futures Settle Lower -- Market Talk

4. Aug. 2025, 19:28 UTC

Market Talk

U.S. Hiring Expected to Recover Once Uncertainty Dissipates -- Market Talk

4. Aug. 2025, 19:07 UTC

Market Talk

Oil Extends Losing Streak As OPEC+ to Raise Output -- Market Talk

4. Aug. 2025, 18:27 UTC

Market Talk

Gold Climbs on Rate Cut Speculation -- Market Talk

Peer-Vergleich

Kursveränderung

Hufvudstaden AB (Class A) Prognose

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Hufvudstaden AB (Class A)

Hufvudstaden AB (publ) engages in the ownership, development, and management of commercial properties in Stockholm and Gothenburg, Sweden. The company operates through three segments: Property Management, NK Retail, and Other Operations. It offers office and retail properties, residential properties, restaurants, department stores, parking facilities, and shopping centres. The company operates its properties primarily under the NK, Bibliotekstan, Femman, Norrmalmstorg 1, Birger Jarlspassagen, Fredstan, Cecil Coworking, Parkaden, and Nordstan brands. It owns properties with rentable floor spaces. Hufvudstaden AB (publ) was founded in 1915 and is headquartered in Stockholm, Sweden.